stockportfolio.pro logostockportfolio.pro
Stocks Screener Start 7-day free trial
Stocks / IDXX / Revenue

IDEXX Laboratories, Inc. Revenue 2008–2025

IDEXX Laboratories, Inc. (IDXX) annual revenue by fiscal year, computed from SEC filings. Compound growth +8.8%/yr over 17 years.

Fiscal yearRevenueChange (YoY)
FY 2025$4.30B+10.4%
FY 2024$3.90B+6.5%
FY 2023$3.66B+8.7%
FY 2022$3.37B+4.7%
FY 2021$3.22B+18.8%
FY 2020$2.71B+12.5%
FY 2019$2.41B+8.8%
FY 2018$2.21B+12.4%
FY 2017$1.97B+10.9%
FY 2016$1.78B+10.8%
FY 2015$1.60B+7.8%
FY 2014$1.49B+7.9%
FY 2013$1.38B+6.5%
FY 2012$1.29B+6.1%
FY 2011$1.22B+10.4%
FY 2010$1.10B+7.0%
FY 2009$1.03B+0.7%
FY 2008$1.02B

Source: IDEXX Laboratories, Inc. SEC filings — income statement (10-K). Refreshed nightly.

See the full picture for IDEXX Laboratories, Inc.

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

IDEXX Laboratories, Inc. — frequently asked questions

What is IDEXX Laboratories, Inc.'s revenue?

IDEXX Laboratories, Inc. (IDXX) reported revenue of $4.30B for fiscal year 2025, per its SEC filings.

How has IDEXX Laboratories, Inc.'s revenue changed over time?

Between fiscal 2008 and 2025, IDXX's revenue grew at roughly 8.8% per year (compound annual rate), from $1.02B to $4.30B.

Where does this data come from?

Figures are computed from IDEXX Laboratories, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.

More IDXX financial history

Full IDXX fundamentals page → · All 1,500+ companies →